In this series, ‘Genomics 101’, we go back to basics and explore some of the most important topics in genomics. In this blog, we explain the term ...

In this explainer episode, we’ve asked John Pullinger, Senior Bio Sample Operations Manager at Genomics England, to explain what it means to go on a diagnostic odyssey. You can also find a series of ...

The Genome Analysis team at Genomics England are working to develop cutting-edge genome analysis approaches to apply in the clinic. They aim to enable world-leading personalised healthcare that is ...

At Genomics England, we hold data for over 15,000 participants with cancer in the National Genomic Research Library (NGRL). Whole genome sequencing for these participants can lead to improvements in ...

At Genomics England, we are committed to transforming health outcomes through innovation in genomics that benefit all patients, regardless of their background. Our Diverse Data Initiative is leading ...

In this series, ‘Genomics 101’, we go back to basics and explore some of the most important topics in genomics. In this blog, we explain what it means to go on a diagnostic odyssey. The term ‘odyssey’ ...

We use cookies to personalise content and to analyse our traffic and improve our website. This website relies on sessions to maintain data across web requests. That is done through the use of a ...

New research has identified a novel mechanism driving osteosarcoma – an aggressive paediatric bone cancer – providing insights to help predict patient outcomes and improve the condition’s management.

The Machine Learning team use machine learning and advanced data analytics to support progress for patients and research partners. Researchers and clinicians detect conditions by using different kinds ...